$CHKP

Check Point (CHKP) Q2 2026 Earnings Call Transcript

Check Point (CHKP) reported Q2 2026 revenue of $674M, up 1% YoY, driven by 12% growth in subscription revenue to $333M, while product revenue fell 14%. Non-GAAP EPS was $2.55, up 8%. Deferred revenue rose to $2.025B. Q3 guidance: revenue $665M-$685M, non-GAAP EPS $2.43-$2.53. Management reaffirmed FY2026 outlook and expanded its $2B buyback.

Original reporting
Published Aug 8, 2026, 2:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 2:39 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Check Point (CHKP) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$CHKPNeutralMed
01

Why it matters

Traders can update models using the explicit Q3 guidance ranges and the disclosed drivers: subscription strength, product revenue decline, gross margin pressure from memory costs, and deal timing pushing billings into later periods.

02

Market read

The call provides fresh, tradable inputs: Q3 revenue/EPS/free-cash-flow guidance, reaffirmed FY2026 outlook, and a quantified capital return update via a $2B buyback authorization.

03

What to watch

Gross margin was slightly impacted by higher memory costs, and management expects sales hiring to affect results in 2027, which could pressure near-term operating leverage despite buybacks.

Relevance 9/10Novelty 8/10Timing: Q3 guidance and FY2026 reaffirmation disclosed in the earnings call (pre-market/early session context).

Background

This is Check Point’s Q2 2026 earnings call transcript with detailed financial metrics, guidance, and product strategy updates (AI Network Firewall, open platform approach).

Company-level read

Ticker impact

$CHKPNeutralMedium confidence
Context

Check Point reported Q2 results and guided Q3 revenue, subscription revenue, non-GAAP EPS, and adjusted free cash flow, plus reaffirmed FY2026 outlook.

Expected impact

Near-term trading likely hinges on whether investors buy the trough-then-recovery narrative and the Q3 guidance ranges versus expectations.

Evidence & confidence

Key decision inputs are the disclosed Q2 datapoints (revenue, EPS, deferred revenue, RPO) and explicit Q3 guidance ranges, alongside management commentary on product weakness and deal timing pushed into Q4.

Market effects

Cybersecurity peers may see read-through on demand durability for subscription security platforms versus firewall appliance hardware.

EMEA and Americas each at 44% of revenue mix, suggesting any regional budget shifts could matter for near-term demand signals.

AI security and low-latency GPU-level integration messaging may influence broader investor framing of AI-driven security spend.

Counterpoint

The emerging-tech growth could be masking ongoing weakness in core firewall appliances, and the trough narrative may extend if large deals keep slipping into later quarters.

Key entities

  • Check Point

    Reported Q2 2026 results, guided Q3 2026, reaffirmed FY2026 outlook, and discussed AI Network Firewall and go-to-market expansion.

  • Nadav Zafrir

    CEO who introduced the AI Network Firewall and discussed AI-driven changes in adversarial capabilities and remediation approach.

  • Roei Golan

    CFO who attributed product revenue decline to firewall appliance demand weakness and go-to-market disruption, and discussed back-ended billings from large deals.

Related articles

$CHKPMed

Check Point SmartConsole Authentication Bypass Is Under Active Attack, and a PoC Is Now Public

Check Point said active attacks target a SmartConsole authentication bypass in its Security Management and Multi-Domain Management servers. The flaw, CVE-2026-16232 (CVSS 9.3), can let an unauthenticated attacker obtain full admin access to the management plane under specific configurations. Rapid7 published analysis and a public PoC; CISA added the CVE to its Known Exploited list.

$CHKPMedAI 8/10

Check Point Software Technologies Q2 Earnings Call Highlights

Check Point (NASDAQ:CHKP) reported Q2 deferred revenue up 7% to $2.025B and remaining performance obligation up 7% to $2.55B. Current RPO rose 4% to $1.6B. Gross profit was $588M with 87% gross margin. Q3 guidance: revenue $655M-$685M, non-GAAP EPS $2.43-$2.53, adj. FCF $235M-$265M. CEO announced an AI Network Firewall and said sales hiring targets 300 roles for 2027.

$CHKPMed

Mixed results disappoint Check Point’s investors

Check Point Software Technologies (Nasdaq: CHKP) reported Q2 revenue of $674 million, slightly below analysts’ expectations, up 1.3% year over year. Security subscriptions rose to $333 million, but products and licenses fell 14% to $113 million. GAAP net profit was $194 million; non-GAAP profit $264 million, EPS $2.55. Shares fell 6.87% premarket.

$MSFTMed

Microsoft rally offsets Fed jitters; Quanta, Huntington Ingalls gain By Investing.com

U.S. stock index futures rose as Microsoft rallied after a fiscal Q4 2026 earnings beat, with revenue of $90.01B (+18% YoY) and non-GAAP EPS of $4.74. Quanta Services and Huntington Ingalls also gained on better-than-expected results and contract updates. Meta fell after earnings; other movers included Check Point, Capricor, Align, Hyatt, Sirius XM, Trinity, and ImmunityBio.

$CHKPHighAI 9/10

Why is Check Point Software stock sliding today? By Investing.com

Investing.com reports Check Point Software (CHKP) shares fell about 8.1% in pre-open trading after Q2 2026 results missed Wall Street revenue expectations and the company reduced its full-year revenue guidance. Analysts expected roughly $675M revenue and about $2.45 EPS. JPMorgan and Raymond James downgraded the stock, and insiders sold about $9.6M of shares.

$CHKPMedAI 9/10

Check Point Software Reports 2026 Second Quarter Financial Results

Check Point Software Technologies (NASDAQ: CHKP) reported Q2 2026 results for the quarter ended June 30. Total revenue was $674 million, up 1% YoY, with security subscriptions at $333 million, up 12%. GAAP EPS was $1.87. Non-GAAP EPS was $2.55. RPO rose to $2.6 billion. The company reported $170 million operating cash flow and $161 million adjusted free cash flow.